Immediate Impact
66 standout
Citing Papers
Persistent physical symptoms: definition, genesis, and management
2024 Standout
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2023 Standout
Works of H. De Cuyper being referenced
Mianserin and chronic pain: a double‐blind placebo‐controlled process and outcome study
1993
Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double‐blind comparative study
1992
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| H. De Cuyper | 325 | 272 | 31 | 66 | 14 | 593 | |
| Juhaní Partanen | 103 | 211 | 49 | 121 | 21 | 669 | |
| Mónika Salgueiro | 332 | 255 | 183 | 8 | 22 | 549 | |
| Peter M. Wolsko | 84 | 248 | 62 | 50 | 8 | 734 | |
| V Rajmohan | 179 | 86 | 154 | 22 | 22 | 664 | |
| Nicholas G. Ward | 133 | 143 | 99 | 30 | 21 | 526 | |
| Robert Marks | 107 | 227 | 38 | 184 | 14 | 644 | |
| Gordon Ko | 356 | 405 | 75 | 46 | 19 | 650 | |
| Kamila Osypiuk | 216 | 84 | 81 | 24 | 19 | 615 | |
| Charles Lake | 99 | 48 | 78 | 11 | 7 | 697 | |
| Ayşen Yücel | 124 | 206 | 307 | 115 | 16 | 661 |
All Works
Login with ORCID to disown or claim papers
Loading papers...